Metformin Alleviates Radiation-Induced Skin Fibrosis via the Downregulation of FOXO3. by �삤�긽�샇 et al.
Cell Physiol Biochem 2018;48:959-970
DOI: 10.1159/000491964
Published online: July 23, 2018 959
Cellular Physiology 
and Biochemistry
© 2018 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
Kim et al.: Metformin Regulates Radiation-Induced Skin Fibrosis
Original Paper
Accepted: May 25, 2018
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna-
tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution 
for commercial purposes as well as any distribution of modified material requires written permission.
I: 0.1159/0 491964
lished online: July 23, 2018
© 2018 The Author(s) 
Published by S. Karger AG, Basel
www.karger.com/cpb
© 2018 The Author(s)
Published by S. Karger AG, Basel
Metformin Alleviates Radiation-Induced 
Skin Fibrosis via the Downregulation of 
FOXO3
Jin-Mo Kima    Hyun Yooa    Jee-Youn Kima    Sang Ho Ohb    Jeong Wook Kanga
Byung Rok Yooa    Song Yee Hana    Cha Soon Kimc    Won Hoon Choia
Eun-Jung Leea   Hyeong Ju Byeona    Won Jai Leed    Yun-Sil Leee    Jaeho Choa
aDepartment of Radiation Oncology, Yonsei University Health System, Seoul, bDepartment of 
Dermatology, Yonsei University Health System, Seoul, cRadiation Epidemiology Team, Radiation Health 
Institute KHNP, Seongnam-si, dDepartment of Plastic Surgery, Yonsei University Health System, Seoul, 
eGraduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, South Korea
Key Words
Radiation-induced skin fibrosis • Metformin • FOXO3 • PIK3r1
Abstract
Background/Aims: Radiation-induced skin fibrosis is a common side effect of clinical 
radiotherapy. Our previous next-generation sequencing (NGS) study demonstrated the 
reduced expression of the regulatory α subunit of phosphatidylinositol 3-kinase (PIK3r1) in 
irradiated murine skin. Metformin has been reported to target the PIK3-FOXO3 pathway. 
In this study, we investigated the effects of metformin on radiation-induced skin fibrosis. 
Methods: Metformin was orally administered to irradiated mice. Skin fibrosis was analyzed 
by staining with H&E and Masson’s trichrome stain. The levels of cytokines and chemokines 
associated with fibrosis were analyzed by immunohistochemistry and quantitative RT-PCR. The 
roles of PIK3rl and FOXO3 in radiation-induced skin fibrosis were studied by overexpressing 
PIK3rl and transfecting FOXO3 siRNA in NIH3T3 cells and mouse-derived dermal fibroblasts 
(MDF). Results: The oral administration of metformin significantly reduced radiation-induced 
skin thickening and collagen accumulation and significantly reduced the radiation-induced 
expression of FOXO3 in murine skin. Additionally, the overexpression of PIK3r1 reduced the 
radiation-induced expression of FOXO3, while FOXO3 silencing decreased the radiation-
induced expression of TGFβ in vitro. Conclusions: The results indicated that metformin 
suppresses radiation-induced skin injuries by modulating the expression of FOXO3 through 
PIK3r1. Collectively, the data obtained in this study suggested that metformin could be a 
potent therapeutic agent for alleviating radiation-induced skin fibrosis.
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IntroductionRadiation therapy (RT) is widely used to treat various types of cancers; however, it can induce toxicity to the surrounding normal tissues [1-4]. Since skin is often irradiated during RT, radiation may lead to inadvertent and deleterious skin reactions. Although the recent use of hypofractionated radiotherapy, including stereotactic body radiotherapy (SBRT), produces less damaging effects on the skin, some reports on the use of SBRT for early lung cancer and breast cancer indicate increased skin toxicities [3, 4]. Radiation-induced skin injuries include acute and chronic skin injuries, comprising of morphological and functional changes. Acute skin injury is characterized by erythema, dry and moist desquamation, and hair loss, while 
chronic skin injury is characterized by fibrosis and necrosis [5]. Unfortunately, apart from conservative management, only few preventive measures or effective remedies are presently available for the treatment of radiation-induced skin damage [6, 7].Advances in cellular and molecular biology techniques have made it possible to elucidate 
the mechanisms of fibrosis, while offering new theoretical treatment strategies. However, 
the cause behind the continued fibroblast activation in chronic fibrosis remains unknown [8, 
9]. Over the years, fibrosis had been considered to be an irreversible accumulation of dead scar tissues. Recent reports have revealed that it is a dynamic process, consisting of constant 
“remodeling” and the long-term activation of fibroblasts. Various factors contributing to 
fibrosis have been identified, and many antioxidant studies have shown that these agents are 
effective for radiation-induced fibrosis (RIF) [10, 11]. Despite these studies, few treatments 
for RIF are in use.Metformin, which belongs to the biguanide family of anti-diabetic drugs, is a primary 
drug for the treatment for type 2 diabetes. Metformin has been shown to inhibit the TGFβ-
signaling pathway during the differentiation of myofibroblasts and cardiac fibrosis [12, 13]. Treatment with metformin was also shown to reduce the accumulation of collagen in 
a bleomycin-induced pulmonary lung fibrosis [14], while attenuating pulmonary fibrosis 
induced by radiation in a mouse model [15]. However, the specific molecular mechanism by 
which metformin suppresses the radiation-induced skin fibrosis to be understood.
A complex signaling network involving phosphatidyl inositol 3-kinase (PI3K) regulates 
the proliferation and differentiation of skin cells [16, 17]. PI3K is an obligate heterodimer 
comprising of a regulatory subunit (p85α, PIK3r1) and a catalytic subunit (p110, PIK3ca) 
that is activated by receptor tyrosine kinases [18]. The components functioning downstream 
of the PI3K/AKT signaling cascade include the forkhead box-O (FOXO) family of transcription 
factors [19] and members of the p53 pathway [20], which regulate cell survival, apoptosis, 
and progression through the cell cycle [21, 22]. FOXO plays an important role in the 
transdifferentiation of hematopoietic stem cells (HSCs) in hepatic fibrosis [23] and renal 
fibrosis [24], and has recently been shown by siRNA-mediated silencing [25] to reduce 
the expression of the transforming growth factor β (TGFβ). In addition, p53 was found to 
transactivate FOXO3 in fibroblasts by binding to the second intron of FOXO3 [26].
In this study, we investigated the effect of metformin and the mechanism by which 
metformin regulates the expression of FOXO3 in radiation-induced skin injury. Understanding 
and regulating the expression of FOXO3 might be critical for developing an effective medical 
countermeasure against radiation-induced skin fibrosis.
Materials and Methods
Cell culture
Primary mouse dermal fibroblasts, MDF and a mouse fibroblast cell line, NIH3T3 were grown in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 units/
mL penicillin, and 100 µg/mL streptomycin at 37°C in a humidified 5% (v/v) CO2 atmosphere. 1.0 × 106 cells 
were seeded at about 80% on 60 mm dish and were incubated with serum-free medium for 24 hours and irradiated.
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Western blot analysis
Cells were lysed with radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl, pH 7.4, 1% 
Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, and 1 mM Na3VO4) containing protease inhibitors 
(2 mM phenylmethylsulfonyl fluoride, 100 µg/ml leupeptin, 10 µg/ml pepstatin, 1 µg/ml aprotinin, and 2 
mM EDTA) and phosphatase inhibitor cocktail (GenDEPOT, Baker, TX). After the extract was incubated for 
20 minutes at 4°C, the lysates were centrifuged at 13, 000 rpm for 20 minutes at 4°C, and the supernatants 
were collected for Western blotting. The protein concentration was measured using a BCA protein kit 
(Bio-rad USA). The lysates were loaded onto sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGEs) for 
electrophoresis. They were subsequently transferred onto polyvinylidene fluoride membranes (Millipore, 
Bedford, MA, USA). The membranes were incubated with 5% skim milk for 1 hour at room temperature and were probed with primary antibody, followed by incubation with horseradish peroxidase-coupled 
secondary antibody. Proteins were detected with ECL Plus Western blotting detection reagents (Amersham 
Biosciences Co., Piscataway, NJ, USA). 
Transfection
Transient transfections were performed with Efectene (Qiagen; Santa Clara, CA, USA) according to the 
manufacturer’s protocol. In brief, 5.0 × 105 cells were placed in a 60 mm dish the day before the transfection 
and were grown to approximately 70% confluence. Then, cell were transfected with 1µg plasmid DNA for 
PIK3r1 or silencing RNA (si-RNA) 10 nM for FOXO3 or p53 gene (cell signaling). The next day, the transfected 
cells were untreated or treated with radiation (10 Gy) for 24 hours. After 24 hours, cells were harvested for 
protein extraction, real-time qPCR or further analysis. All experiment were performed in triplicate, and representative results were reported.
Quantitative real-time polymerase chain reaction (PCR)
Total RNA was isolated from cells with Trizol Reagent (Invitrogen, Carlsbad, CA, USA) according to the 
manufacturer’s instructions, and the Quantifect Reverse Transcription Kit (Qiagen, Hilden, Germany) was used 
to synthesize cDNA. Real-time PCR reactions included SYBR Premix Ex Taq (Takara), primers, RNase-free H2O, 
and cDNA in a final reaction volume of 20 µl. The real-time PCR cycling conditions were 95°C for 10 minutes, 
followed by 50 cycles of 95°C for 20 sec, 55°C for 30 sec, and 72°C for 20 sec. The sequences of the mouse primers were as follows : IL-1b (FW 5‘-TGGTGTGTGACGTTCCCATT-3‘; RW 5’-CAGCACGAGGCTTTTTTGTTG-3‘), 
IL-6 (FW 5‘-ACAAGTCGGAGGCTTAATTACACAT-3‘; RW 5‘-TTGCCATTGCACAACTCTTTTC-3‘), 
IL-8 (FW 5‘-CTCCAGCCACACTCCAACAGA-3‘; RW 5‘-CACCTAACACACCCACGAT-3‘), TGFβ 
(FW 5‘-GCAACATGTGGAACTCTACCAGAA-3‘; RW 5‘-GACGTCAAAAGACAGCCACTC-3‘), CCL2 
(FW 5‘-GCTGACCCCAAGAAGGAATG-3‘; RW 5‘-GTGCTTGAGGTGGTTGTGGA-3‘), CCL4 (FW 
5‘-CCAGGGTTCTCAGCACCAA-3‘; RW 5‘-GCTCACTGGGGTTAGCACAGA-3‘), CXCL10 (FW 
5‘-CCTCATCCTGCTGGGTCTG-3‘; RW 5‘-CTCAACACGTGGGCAGGA-3‘). All experiments were performed 
in triplicate and were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression. 
The values of mRNA were calculated using the delta Ct method and expressed as change relative to the 
expression of GAPDH mRNA as an internal control.
Irradiation and oral administration of metformin
All animal procedures used in the present study were approved by the Yonsei University Health System-
Institutional Animal Care and Use Committee (YUHS-IACUC; 2016-0199) and were performed in accordance with the relevant guidelines and regulations. C57BL/6 mice (age, 6 weeks; weight, 20–25 g) were purchased 
from Charles River Korea (Orient Bio, Seongnam, South Korea) and allowed to acclimatize (n = 5 per cage) for a week before irradiation. Mice were anesthetized with an intraperitoneally administered mixture of 
30mg/kg Zoletil (tiletamine and zolazepam) and 10 mg/kg of Rompun (xylazine) and irradiated. Mouse 
irradiation and dosimetry were performed as previously described [27]. Briefly, radiation was delivered 
with an X-RAD 320 (Precision, North Branford, USA), equipped with fixed and adjustable collimation 
fixtures. The collimators produced a beam with a 1 cm x 1 cm coverage area. The aluminum-filtered X-ray 
beam dose rate was 8.3 cGy/s, measured at 320 kV and 12.5 mA using a cylindrical ionization Farmer-
type chamber (PTW 0.6 cm2, waterproof) within an RW3 phantom at a source-to-surface distance of 2 cm. 
Radiation dosimetry for cultured cells was carried out using a 60 mm dish, water, and RW3 phantom slab, 
and GAFCHROMIC EBT3 film. The cell culture dishes were filled with water. EBT3 film was placed in the 
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bottom of each dish for radiation dose assessment. In this experiment, cells were administered 10 Gy in one fraction.
Metformin was dissolved in distilled water, diluted with carboxymethylcellulose (0.5% w/v), and 
was orally administered in a single dose (50 or 100 mg/kg) three times a week after a day of radiation 
exposure to a single 30 or 50 Gy fraction of radiation on the dorsal skin of mice. On the sixth week following 
irradiation, the mice were sacrificed, and the skin tissues were collected for further analyses
Preparation of skin tissues and staining
Skin tissues were fixed in a 4% paraformaldehyde solution and then embedded in paraffin. Sections 
of skin tissue, 4 μm thick, were stained with hematoxylin and eosin (H&E) and Masson’s trichrome (Sigma-
Aldrich, St. Louis, MO, USA) according to the manufacturers’ instructions. As shown in Fig 1A (top), the 
histology of skin tissue shows epidermis, dermis and subcutaneous layer in order from top to bottom. For 
immunohistochemistry, skin tissues were incubated at 4°C overnight with an anti-FOXO3 or anti-8-OHdG 
(Abcam, Cambridge, MA, USA) primary antibody. After the tissue slides were incubated with avidin-biotin 
peroxidase complex (ABC kit, Vector Laboratories, Burlingame, CA, USA), the color was developed with 
3, 3‘-diaminobenzidine tetrachloride (DAB; Zymed Laboratories, CA, USA). After immunohistochemical 
staining, the slides were counterstained with Harris’s hematoxylin for 1 min and then mounted with Canada 
balsam (Sigma-Aldrich, St. Louis, MO, USA). For immunofluorescence staining, skin tissues were incubated 
overnight with anti-SMA or anti-FOXO3 (Abcam, Cambridge, MA, USA) that were diluted in PBS containing 
0.5% BSA and were subsequently incubated for 2 hours at room temperature with secondary fluorescent-
conjugated secondary antibodies that were diluted in PBS containing 0.5% BSA. And, these were mounted 
on gelatin-coated slide with fluorescent mounting medium (Dako, Glostrup, Denmark) and dried.
Immunocytochemistry
After culturing on coverslips coated with poly-L-lysine, the cells were fixed with 4% paraformaldehyde 
in PBS and permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature. After several washes 
with PBS, cell were incubated with the FOXO3 primary antibody at 4°C overnight, after blocking with 1% 
bovine serum albumin in PBS. Next, the cells were stained with a secondary antibody that was conjugated 
with Texas Red and subsequently stained with DAPI. The coverslips were then mounted and the fixed, 
stained cells were observed using a confocal fluorescence microscope.
Statistical analysis
The difference between the means of two study groups was evaluated by the Student’s t-test. Differences 
between the means of multiple groups were evaluated by one-way analysis of variance (ANOVA) followed 
by Dunnett’s multiple comparison test. The threshold for statistical significance was p<0.05 for both tests. 
All values are expressed as the mean ± SEM. Statistical significance was evaluated using the GraphPad Prism 
(GraphPad Software, La Jolla, CA, USA).
Results
Radiation-induced skin damage
In order to investigate the histologic changes and the deposition of collagen in the dorsal 
skin of mice irradiated with 30 Gy or 50 Gy X-rays in this study, hematoxylin and eosin (H&E) 
staining and Masson’s Trichrome (MT) staining were performed 6-weeks post-irradiation. Both dermal tissue enrichment and progressive collagen deposition were observed in the 
model of radiation-induced mouse skin fibrosis, as demonstrated in Figures 1A-B. In order 
to examine the effect of radiation on the gene expression of inflammatory mediators, we 
measured the expression levels of cytokines, including IL-6 and TGFβ, which play important 
roles during murine inflammatory responses. Using immunohistochemistry (Fig. 1C), we 
observed a significant increase in their expression in irradiated murine skin tissues compared with that in the control group. Additionally, the effect of irradiation on the expression of 
pro-inflammatory cytokines and chemokines was investigated by irradiating the cell lines of 
normal mouse fibroblasts (NIH3T3) and normal primary mouse dermal fibroblasts (MDF) 
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in vitro. As shown in Fig. 1D, irradiation significantly increased the expression of various 
inflammatory cytokines and chemokines, such as IL-1b, IL-8, CCL2, CCL4, and CXCL10, as 
well as those of IL-6 and TGFβ in both NIH3T3 and MDF cell lines.
As aforementioned, the models of radiation-induced mouse skin fibrosis develop 
dermal thickening, fibrosis, alopecia, and display the increased expression of inflammatory cytokines, all of which closely resemble the characteristics of human skin injuries resulting from radiotherapy. Therefore, these models may be ideal studying the effects of radiation-
induced skin injury, especially at the histological and molecular level [28].
Fig. 1. Radiation-induced skin tissue damage. A) Representative images of skin tissues that 
were irradiated with 30 Gy or 
50 Gy in mouse skin tissue, sampled at 6 weeks, and stained 
with H&E or MT. Irradiated sections demonstrated marked thickening of epidermis and 
dermis (100×). B) Quantification of relative skin thickness and collagen contents. Data are expressed as mean ± standard 
error (***P<0.001, *P<0.05 and **P<0.01, versus control; n = 8; 
con = control). C) Representative immunohistological image of skin tissues that were stained by 
antibody for IL-6 and TGFβ (100×). 
D) Cytokine and chemokine gene expression in irradiated NIH3T3 and MDF cells (***P<0.001, *P<0.05 and **P<0.01; n = 3; con = control, IR = irradiated).
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Fig. 2. Metformin inhibited 
radiation-induced fibrosis on 
mice skin tissue. Either 50 or 100 
mg/kg of metformin (Me) was 
administered orally to C57BL/6 mice. The skin samples were obtained by punch biopsies on the sixth week following irradiation at 
a dose of 50 Gy. A) Representative images of skin tissues; irradiated 
group (IR) with 50 Gy were treated with metformin, sampled at 6 
weeks, and stained with H&E or MT. 
Irradiated sections demonstrated marked thickening of epidermis 
and dermis (100×). B) Quantification of relative skin thickness and collagen contents. C) mRNA expression 
of TGFβ, IL-6, and CCL11 using real-time qPCR on skin tissue in mice. D) Representative immunohistological 
image of skin tissues, which were stained by antibody for IL-6 and TGFβ. Data are expressed as mean ± standard error (***P<0.001, *P<0.05 and **P<0.01; n = 3; con = control, IR = irradiated, Me = metformin).
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Metformin inhibits irradiation-induced skin injury in mice
Metformin was orally administered at doses of 50 or 100 mg/kg, three times a week 
after irradiation, in models of radiation-induced mouse skin fibrosis, following which immunohistochemistry assays were performed. To evaluate whether metformin reduces 
dermal thickening and collagen synthesis in the skin, H&E staining and MT staining were 
first performed using the tissues of the model of radiation-induced murine skin fibrosis. 
Following the administration of metformin, the thickness of the dermis, occurrence of 
hyperkeratosis, and the radiation-induced accumulation of collagen (Fig. 2A and 2B) were 
significantly reduced, while the mRNA (Fig. 2C) and protein (Fig. 2D) expression of radiation-
induced inflammatory cytokines and chemokines, including TGFβ, IL6, and chemokine 11 
(CCL 11), were suppressed in the murine tissues. The irradiated NIH3T3 and MDF cells were 
subsequently treated with metformin, and analyzed by real-time qPCR and western blots, in 
order to confirm the in vitro effects of metformin. The protein levels of the pro-inflammatory 
cytokines TGFβ and IL-6, and CCL11, decreased in a dose-dependent manner, following 
treatment with metformin in the NIH3T3 cell lines (Fig. 3A). Also, the mRNA levels of TGFβ, 
IL-6, and CCL11 decreased following the treatment of the MDF and NIH3T3 cell lines with 
metformin (Fig. 3B and 3C).
Fig. 3. Metformin reduced irradiation-induced cytokines and chemokine expression in vitro. NIH3T3 cells and 
MDF cells were treated with metformin 
(Me; 10 or 20 µM) for 30 minutes before 
irradiation (10 Gy). A) In NIH3T3 cells, 
protein expression of TGFβ, IL-6, and 
CCL11 were evaluated with Western blot 
using antibody for TGFβ, IL-6, and CCL11. 
B, C) mRNA expression of TGFβ (B), IL-6, 
and CCL11(C) in NIH3T3 cells and MDF 
cells, using quantitative real-time PCR. 
Data are expressed as mean ± standard error (***P<0.001, *P<0.05 and **P<0.01; 
n = 3; con = control, IR = irradiated, Me = metformin).
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Fig. 4. Metformin decreased radiation-induced STAT3 expression and oxidative stress. Metformin (Me) was orally 
administered at a dose of 100 mg/kg to 
C57BL/6 mice. The skin samples were obtained by punch biopsies on the sixth 
week following irradiation at a dose of 50 
Gy. NIH3T3 were treated with metformin 
(Me; 10 or 20 µM) for 30 minutes before 
irradiation (10 Gy). Gene expressions 
in 10 Gy-irradiated cells at 1 hour and 
4 hours, in NIH3T3. A) Representative immunohistological image of skin tissues 
that were stained by anti-STAT3 (100×). 
B, C) mRNA expression of STAT3 was evaluated by quantitative real-time RT-PCR on skin tissue of mice (B) 
and in NIH3T3 cells (C). D) Representative immunohistological image of skin tissues that were stained by 
antibody for 8-OHdG (100×). E) Quantification of relative expression of 8-OHdG. Data are expressed as mean 
± standard error (***P<0.001, *P<0.05 and **P<0.01, ; n = 3; con = control, IR = irradiated, Me = metformin).
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In addition, the expression levels of STAT3 mRNA and protein were reduced by 
metformin in models of radiation-induced murine skin fibrosis, as shown in Figures 4A and 4B, respectively. Metformin also suppressed the expression of STAT3 that had been induced by radiation in vitro (Fig. 4C). And the radiation-induced expression of 8-OHdG, which served as a biomarker for oxidative stress [29], decreased in murine tissues following treatment 
with metformin (Fig. 4D and 4E).
Therefore, these results suggested that metformin significantly inhibits the pro-
inflammatory response, and might attenuate radiation-induced skin fibrosis.
Metformin regulates FOXO3 expression and suppresses radiation-induced fibrosis
To determine whether the expression of FOXO3 during skin fibrosis could be regulated 
by metformin, we examined the effect of metformin on FOXO3 expression. Interestingly, 
metformin inhibited the radiation-induced expression of FOXO3 as revealed by the results 
of immunohistochemistry (Fig. 5A) and real-time qPCR (Fig. 5B). Additionally, metformin 
reduced the radiation-induced expression of nuclear FOXO3, which acts as a transcription 
factor (Fig. 5C). The expression of smooth muscle actin (SMA), a marker of fibrosis, was increased by irradiation; however, treatment with metformin suppressed its expression, 
as shown in Fig. 5D. Additionally, the 
expression of FOXO3 was merged with SMA in irradiated murine skin tissues 
(Fig. 5E), while siRNA-mediated silencing 
of the FOXO3 gene suppressed the 
radiation-induced expression of TGFβ 
(Fig. 5F). These results suggested that metformin alleviates radiation-induced 
skin fibrosis by downregulating FOXO3.
FOXO3 regulates radiation-induced 
fibrosis via PIK3rl
This study additionally identified 
that the expression of PIK3r1 
Fig. 5. Metformin alleviated 
radiation-induced fibrosis via 
FOXO3. Metformin (Me) was orally administered at a dose of 
100 mg/kg to C57BL/6 mice. The skin samples were obtained by punch biopsies on the sixth week following irradiation at 
a dose of 50 Gy. NIH3T3 were treated with metformin (Me; 
10 or 20 µM) before irradiation 
(10 Gy). A) Representative immunohistological image of skin tissues that were stained 
by anti-FOXO3 (100×). B) mRNA 
expression of FOXO3 was evaluated 
by quantitative real-time PCR on 
skin tissue in mice. C) NIH3T3 cells were stained with anti-FOXO3 (red). Blue indicates DAPI staining. D, 
E) Skin tissues were stained with anti-FOXO3 (red) and anti-SMA (green). Blue indicates DAPI staining. F) 
NIH3T3 cells were transfected with si-RNA for FOXO3. Cells were lysed and lysates were analyzed for anti-
FOXO3 by Western blotting, and then analyzed by real-time RT-qPCR for TGFβ. Data are expressed as mean 
± standard error (***P<0.001, *P<0.05 and **P<0.01; n = 3; con = control, IR = irradiated, Me = metformin).
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Table 1. Sequencing results by GO pathway
Gene Description log2 Fold  Mylk2 myosin, light polypeptide kinase 2, skeletal muscle -2.750052364 Mylk4 myosin light chain kinase family, member 4 -5.159838576 Ntrk2 neurotrophic tyrosine kinase, receptor, type 2 -2.547840837 Pdk2 pyruvate dehydrogenase kinase, isoenzyme 2 -2.788946035 Phkg1 phosphorylase kinase gamma 1 -2.766287995 Pik3c2g phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide -1.927830068 Pik3r1 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) -1.449235635 Plce1 phospholipase C, epsilon 1 -2.004705134 Ptpn14 protein tyrosine phosphatase, non-receptor type 14 -1.447858686 Rorc RAR-related orphan receptor gamma -1.862459189 Wnk2 WNK lysine deficient protein kinase 2 -1.470070694 
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(phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1; p85 alpha), which is 
a subunit of PI3K and is involved in phosphate metabolism, was reduced, as revealed by 
analyses of the RNA-sequencing data (Table 1) in the model of radiation-induced skin fibrosis. 
The mRNA levels of PIK3r1 decreased in the irradiated murine dorsal skin tissues (Fig. 6A) 
and in irradiated NIH3T3 and MDF cell lines (Fig. 6B) compared with that in the control 
group, as revealed by real-time qPCR analyses. The overexpression of PIK3r1 in NIH3T3 cells 
decreased the expression of TGFβ that had been induced by irradiation (Fig. 6C).
Since PI3K plays an important role in the AMPK-FOXO3 axis [30], this study proceeded 
to investigate whether metformin could regulate the expression of PIK3r1 and FOXO3 
for suppressing skin fibrosis. Interestingly, metformin enhanced the mRNA and protein 
levels of PI3Kr1 that had been suppressed by irradiation, as shown in Figures 6D and 6E, 
respectively. Similar findings were observed for the NIH3T3 cells (Fig. 6F). Additionally, the 
overexpression of PIK3r1 suppressed the radiation-induced expression of FOXO3 (Fig. 6G). 
p53 siRNA reduced radiation-induced FOXO3 expression (Fig. 6H and 6I) and decreased the 
expression of cytokines, such as IL-6, TGFβ, and CCL11 that had been induced irradiation 
(Fig. 6J).Taken together, these results suggested that metformin enhances the expression of 
PIK3r1, which in turn suppresses FOXO3 expression, indicating that metformin may serve as an effective therapy in the treatment of radiation-induced skin injury.
DiscussionRadiotherapy can cause skin damage and result in either the loss or disruption of bone 
and soft tissue vasculature. Exposure of the skin to radiation results in a cascade of cellular 
events, leading to acute and chronic skin injuries. In our previous study, we also performed 
RNA sequencing using next-generation sequencing (NGS) technologies for examining the 
gene expression profiles in normal and irradiated murine skin tissues. After identifying 
682 differentially expressed genes, we classified them using DESeq; the expression of 334 
genes were found to increase, while those of 348 genes decreased following irradiation of the dorsal skin of mice, suggesting that the modulation of the pyruvate metabolic pathway 
via PDK2 suppresses radiation-induced skin injury in mice [27]. In this study, we identified 
Fig. 6. FOXO3 expression was regulated by PIK3r1 
and p53. A, B) mRNA expression of PIK3r1 using 
quantitative real-time RT-PCR that were irradiated 
on skin tissue of mice (A), NIH3T3 and MDF cells 
(B). C) NIH3T3 cells were transfected with p85. 
Cells were analyzed by quantitative real-time 
RT-PCR for TGFβ. D, E) 100 mg/kg of metformin 
(Me) was administered orally to C57BL/6 mice. 
PIK3rl expression was analyzed by quantitative 
real-time RT-PCR (D) and Western blotting (E). 
F) NIH3T3 were treated with metformin (20 µM) 
before irradiation (10 Gy). PIK3rl expressions 
were analyzed by Western blotting. G) NIH3T3 
cells were transfected with p85. FOXO3 expression 
was analyzed by quantitative real-time RT-PCR. 
H-I) NIH3T3 were transfected with si-RNA for p53 
before irradiation (5 or 10 Gy). FOXO3 expressions 
were analyzed by Western blotting (H) and 
quantitative real-time RT-PCR (I). mRNA levels 
for IL-6, TGFβ, and CCL11 (J) were analyzed by quantitative real-time RT-PCR. (***P<0.001, *P<0.05 and **P<0.01; n = 3; con = control, IR = irradiated, Me = metformin).
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that the expression of the subunits of PI3K, including PIKk3c2g (phosphatidylinositol 
3-kinase, C2 domain containing, gamma polypeptide) and PIK3r1 (phosphatidylinositol 
3-kinase, regulatory subunit, polypeptide 1; p85 alpha), decreases following irradiation, as 
demonstrated by the DESeq classification method and real-time qPCR (Table 1). In this study, 
we demonstrated that the expression of PIK3rl is suppressed after exposure to radiation, and 
metformin, which is an AMPK activator, inhibits radiation-induced skin fibrosis by regulating 
the expression of FOXO3 and the components functioning downstream of PIK3rl.
Skin fibrosis is treated by the application of steroid drugs, immunotherapy using 
antibodies, surgical therapy, among others [31]. However, the molecular pathogenesis of these conditions after radiation exposure remains to be elucidated. Metformin is a selective 
AMPK activator that inhibits the TGFβ-signaling pathway mediated by the activation of 
AMPK during fibrosis, including cardiac fibrosis, cystic fibrosis, and gefitinib- or bleomycin-
induced pulmonary fibrosis [12, 32-37]. It also alleviates bleomycin-induced skin fibrosis 
[32, 38], and inhibits TGFβ-induced collagen production in renal fibroblasts of mice [33]. 
However, the effect of metformin on radiation-induced fibrosis is not well-known. Several 
reports have shown that metformin inhibits FOXO3 activity [39, 40] while also playing an 
important role in the AMPK-FOXO3 axis [30, 41]. Numerous studies have also suggested 
that metformin inhibits cardiac and renal fibrosis by regulating the TGFβ signaling pathway, 
which is important in fibrosis [12, 42]. FOXO3, which is regulated by the AMPK signaling 
pathway [43, 44], has been found to be an important mediator of TGFβ gene expression [45]. 
Moreover, the PI3K-AKT signaling pathway negatively regulates the pro-apoptotic forkhead 
transcription factors (FOXO) [16, 17, 19]. Our data showed that metformin significantly reduces the thickness of the skin, the accumulation of collagen, and the expression of 
STAT3, cytokines, and chemokines, including TGFβ, IL-6, and CCL 11, which are associated 
with inflammation and fibrosis during radiation exposure. Therefore, metformin might 
antagonize radiation-induced skin fibrosis in mice. Compared with normal cells, treatment 
with metformin markedly reduced the radiation-induced increase in cell size (Fig. 5C), which 
is a feature of senescent cells [46]. In addition, the onset of senescence in myofibroblasts has 
been found to control fibrogenesis by inducing the deposition of extracellular matrix (ECM) 
during wound healing [47]. We proceeded to examine whether PIK3r1 and FOXO3 could 
affect the pathology of irradiated skin. By analyzing with real-time qPCR, we confirmed that 
PIK3rl-transfected NIH3T3 cells had markedly reduced the expression of TGFβ and FOXO3, 
compared with that of the empty vector-transfected cells. Also, the siRNA-mediated silencing 
of FOXO3 attenuated the radiation-induced expression of TGFβ. These data suggested that 
PIK3r1 downregulates the expression of FOXO3 and that both of them may regulate RIF. Taken together, we suggest that metformin suppressed the radiation-induced expression of 
FOXO3 via PIK3r1. However, future studies will need to address the mechanism by which 
metformin could affect the AMPK-FOXO3 axis during the RIF of skin.
Moreover, we additionally investigated whether p53 regulates RIF by regulating 
the expression of FOXO3. p53 functions downstream of PI3K/AKT [20] and is known to 
transactivate FOXO3 in fibroblasts by binding to the second intron of FOXO3 [26]. In this 
study, we evaluated whether p53 siRNA could inhibit the radiation-induced gene expression 
of cytokines and the expression of FOXO3. We transfected NIH3T3 cells with p53 siRNA 
and measured gene expression by real-time PCR. As expected, p53 siRNA significantly suppressed the radiation-induced gene expression of cytokines and the radiation-induced 
expression of FOXO3 (Fig. 6H-J). p53 has been shown to regulate cell fate determination in response to cellular stresses in many cell lines, and is known for its roles in programmed 
cell death. Recent studies have also demonstrated potential crosstalk between p53 and the 
transcription factor, FOXO3. Thus, FOXO3 may also modulate cell death and cell survival [48]. 
Therefore, the precise signaling mechanisms between p53 and FOXO3 that lead to radiation-induced skin damage need to be further investigated.
This study revealed that metformin suppresses radiation-induced skin fibrosis and 
outlined that the mechanism underlying this effect is mediated via the FOXO3 signaling 
pathway. This study is also the first to demonstrate that metformin prevents radiation-
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induced skin inflammation and fibrosis. Our findings further suggested that the therapeutic 
efficacy of metformin may be by its suppression of the expression of FOXO3 via PIK3r1, 
highlighting the potential use of metformin as a novel anti-fibrotic agent for the treatment of radiation-induced skin injuries.
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